Dr Mone PhD MSc FRCPI MRCOG is dual qualified in fetal medicine and prenatal genomics having completed RCOG accredited subspecialty training in Maternal Fetal Medicine and a clinical fellowship/masters in prenatal genomics/genomics. She is a clinical lecturer at the Centre for Public Health as part of the Molecular Epidemiology and Public Health Research Group and is an honorary consultant in obstetrics and fetal medicine at the Royal Jubilee Maternity Service, BHSCT. 

She has been editor for Ultrasound in Obstetrics and Gynecology related to genetics manuscripts primarily since 2021  and also serves as an invited ISUOG faculty member, teaching on the pre-congress course and chairing a masterclass at ISUOG 2023. Dr Mone also demonstrates international expertise in prenatal genomics by serving as a co-chair for the ISPD SIG on Fetal Imaging and Phenotyping, organising and chairing relevant sessions for ISPD as well as performing abstract judging and being involved in providing educational sessions. She is elected abstract co-ordinator for the British Maternal Fetal Medicine Society where she organises the annual conference and judges abstracts as well as being a committee member for the Fetal Genomics Group of the British Society of Genomic Medicine.

Dr Mone is currently an elected member of the RCOG scientific impact committee for whom she has authored the SIP on prenatal exome sequencing and is currently part of the working group writing the RCOG green-top guideline on NIPT. 

Research interests include fetal medicine, prenatal genomics, next generation sequencing, screening, fetal therapy and maternal medicine

Current proposed PhD projects include:

1. Obtaining a genetic Diagnostic Yield via assessment of in-utero Scan findings prior to the introduction of SEquencing retrospectivelY (ODYSSEY) - a cohort study

2. Assessment of cardiovascular biomarkers in the maternal and fetal circulation in cardiac disease & pre-eclampsia 

3. A NOvel VAginal Ring device for Infection screeniNG (NOVARING) - a feasibility and acceptability study

4. Targeted Antibiotic use via a Rapid point-of-care test for Group B strep and E-coli prevention in established labour via LAMP Technology (TARGET-1) - a feasibility study 

5. Establishing the optimal first trimester aneuploidy screening approach for Northern Ireland – a mixed methods implementation science study